Genetic heterogeneity in breast cancer: the road to personalized medicine?
Open Access
- 18 June 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in BMC Medicine
- Vol. 11 (1), 151-5
- https://doi.org/10.1186/1741-7015-11-151
Abstract
More women die from breast cancer across the world today than from any other type of malignancy. The clinical course of breast cancer varies tremendously between patients. While some of this variability is explained by traditional clinico-pathological factors (including patient age, tumor stage, histological grade and estrogen receptor status), molecular profiling studies have defined breast cancer subtypes with distinct clinical outcomes. This mini-review considers recent studies which have used genomics technologies in an attempt to identify new biomarkers of prognosis and treatment response. These studies highlight the genetic heterogeneity that exists within breast cancers in space and time.This publication has 30 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Whole-genome analysis informs breast cancer response to aromatase inhibitionNature, 2012
- Mutational Processes Molding the Genomes of 21 Breast CancersCell, 2012
- The Life History of 21 Breast CancersCell, 2012
- The landscape of cancer genes and mutational processes in breast cancerNature, 2012
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroupsNature, 2012
- Initial genome sequencing and analysis of multiple myelomaNature, 2011
- Genome remodelling in a basal-like breast cancer metastasis and xenograftNature, 2010
- A comprehensive catalogue of somatic mutations from a human cancer genomeNature, 2009
- Genomic and transcriptional aberrations linked to breast cancer pathophysiologiesCancer Cell, 2006